ActualEyes Inc.
Industry / private company
Location:
Kyotanabe,
Japan (JP)
Therapeutic Potential of Emricasan, a Pan-Caspase Inhibitor, in Reducing Cell Death and Extracellular Matrix Accumulation in Fuchs Endothelial Corneal Dystrophy (2025)
Fujimoto S, Endo M, Tonomura S, Tsuji F, Haraguchi H, Hasegawa K, Numao T, et al.
Journal article
Deep neural network by transfer learning for the analysis of guttae in the patients with Fuchs endothelial corneal dystrophy (2021)
Narimoto K, Okumura N, Yamada S, Okamura K, Izumi A, Tourtas T, Kruse F, Koizumi N
Conference contribution